Results 41 to 50 of about 80 (65)

Identification and validation of biomarkers for autism spectrum disorders

Nature Reviews Drug Discovery, 2015
Eva Loth, Tobias Banaschewski, Simon Baron-Cohen   +2 more
exaly  

Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries

World Psychiatry, 2017
Anthony F Jorm, Traolach Brugha
exaly  

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Nature Reviews Drug Discovery, 2016
Anton Bespalov, Bruce Altevogt, Daniel Deaver   +2 more
exaly  

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

Nature Reviews Drug Discovery, 2011
Alan H Nagahara, Mark H Tuszyński, Tuszyński Mark H   +2 more
exaly  

Somatoform Disorders

2010
Adria O. Winter, Thomas B. Purcell
openaire   +1 more source

Two decades of new drug development for central nervous system disorders

Nature Reviews Drug Discovery, 2015
, Thomas J Hwang, Jessica M Franklin
exaly  

Bipolar disorders

Nature Reviews Disease Primers, 2018
Eduard Vieta, Michael Berk, Thomas G Schulze   +2 more
exaly  

Moving from 'diagnose and treat' to 'predict and pre-empt' in neuropsychiatric disorders

Nature Reviews Drug Discovery, 2015
Vaibhav A Narayan, Narayan Vaibhav A, Manji Husseini K   +2 more
exaly  

Gene therapy for neurological disorders: progress and prospects

Nature Reviews Drug Discovery, 2018
Benjamin E Deverman, Steven M Paul, Deverman Benjamin E   +2 more
exaly  

Exfoliative Cytology in Disorders of the Colon: A Preliminary Report

Ca-A Cancer Journal for Clinicians, 1954
exaly